Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy

NCT01490775 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Study was terminated due to lack of funding

Conditions

Chronic Phase CML

Interventions

BEHAVIORAL: no access to eMedonline
BEHAVIORAL: eMedonline access

Sponsor

Rex Cancer Center, Raleigh, NC

Collaborators

[object Object]